Rare diseases
Investigational molecules
Locations
Piazzale Giulio Cesare 11, 70124 Bari, Italy
Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari in Bari, Italy specialises in clinical trials of conditions such as Type 2 diabetes mellitus, Acute myeloid leukaemia, IgA nephropathy, Partial seizures, and other specialisations. This site conducts important research.
The medical center is at the forefront of hematology and oncology research, focusing on innovative treatments for blood cancers. The center's commitment to advancing therapeutic options is evident through its involvement in cutting-edge clinical trials.
By exploring novel agents like quizartinib, the center aims to improve survival outcomes and quality of life for patients with challenging hematologic malignancies.
Clinical trials currently enrolling participants at this site.
Study of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease
ItalyItalyStudy of DNTH103 Treatment for Adults with Chronic Inflammatory Demyelinating Polyneuropathy: Comparing Effectiveness with Placebo
ItalyItalyStudy of atropine eye drops (0.
ItalyStudy of Vemurafenib and Rituximab for Untreated Hairy Cell Leukemia Patients
ItalyStudy of BCG Vaccine and Sodium Chloride for Patients with Radiologically Isolated Syndrome (RIS)
ItalyStudy on Atrasentan for Patients with IgA Nephropathy at Risk of Kidney Function Loss
ItalyStudy on Medulloblastoma Treatment in Children Aged 3-5 Using Carboplatin and Drug Combination
ItalyStudy on Ependymoma Treatment in Children, Adolescents, and Young Adults Using Cisplatin, Cyclophosphamide, Etoposide, and a Drug Combination
ItalyStudy on High-Risk Neuroblastoma Treatment with Busulfan, Melphalan, and Drug Combination for Patients with Insufficient Metastatic Response
ItalyStudy of Palbociclib and Fulvestrant for Women with Advanced Breast Cancer After Previous CDK4/6 Inhibitor and Hormonal Therapy
ItalyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
